Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Syndactyly type 8 is a rare, genetic, non-syndromic, congenital limb malformation characterized by unilateral or bilateral fusion of the fourth and fifth metacarpals with no other associated abnomalities. Patients present shortened fourth and fifth metacarpals with excessive separation between their distal ends, resulting in marked ulnar deviation of the little finger and an inability to bring the fifth finger in parallel with the other fingers.
Features include always present findings: Short 5th metacarpal and 4-5 metacarpal synostosis; and common findings: 2-3 toe cutaneous syndactyly and Clinodactyly of the 5th finger.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Arms and legs | 2 | 2-3 toe cutaneous syndactyly, Clinodactyly of the 5th finger |
FGF16 encodes fibroblast growth factor 16 (207 aa). Plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation, and is required for normal cardiomyocyte proliferation and heart development Highest expression in Adipose Subcutaneous (0.6 TPM) and Breast Mammary Tissue (0.4 TPM).
Syndactyly type 8 is associated with mutations in the FGF16 gene on chromosome X.
FGF16 is classified as a druggable target (Druggable Genome and Growth Factor categories) with score 0.0.
Genetic testing for FGF16 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 2 common features.
No clinical trials have been registered for syndactyly type 8.
8 publications have been identified in PubMed for syndactyly type 8. Research spans Basic Science / Preclinical (38%), Case Report / Case Series (25%), and Review / Meta-Analysis (13%).
Pattani N (2026). [PMID: 41956799](https://pubmed.ncbi.nlm.nih.gov/41956799/). *J Med Genet*. [Case Report / Case Series]
Mokhtari A (2026). [PMID: 40842263](https://pubmed.ncbi.nlm.nih.gov/40842263/). *Clin Genet*. [Basic Science / Preclinical]
Talsania AJ (2025). [PMID: 40358017](https://pubmed.ncbi.nlm.nih.gov/40358017/). *Tech Hand Up Extrem Surg*. [Clinical Trial Publication]
Tolmacheva EN (2025). [PMID: 39985054](https://pubmed.ncbi.nlm.nih.gov/39985054/). *Mol Cytogenet*. [Epidemiology / Natural History]
He X (2025). [PMID: 39564920](https://pubmed.ncbi.nlm.nih.gov/39564920/). *Orthop Surg*. [Case Report / Case Series]
Rigueur D (2024). [PMID: 39632143](https://pubmed.ncbi.nlm.nih.gov/39632143/). *Differentiation*. [Review / Meta-Analysis]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 9:38 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Panebianco CJ (2024). [PMID: 39763848](https://pubmed.ncbi.nlm.nih.gov/39763848/). *bioRxiv*. [Basic Science / Preclinical]
Yousef AT (2024). [PMID: 38623947](https://pubmed.ncbi.nlm.nih.gov/38623947/). *Anat Histol Embryol*. [Basic Science / Preclinical]